Skip to main content
Premium Trial:

Request an Annual Quote

Correction: Apr 12, 2005

Premium

In the 4/5/2005 issue of Cell-Based Assay News, the article “Euroscreen Wins Addional Aequorin Screening Patent; Seeks to Expand Instrument Partners” contained factual errors. EuroScreen has approximately 50 employees in R&D, not 15 as stated in the article. In addition, EuroScreen uses the FMAT8100 high-throughput screening system, which is currently available from Applied Biosystems, and not the discontinued FMAT as stated.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.